Windtree Therapeutics (WINT) Misses Q1 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mailGet Alerts WINT Hot Sheet
Join SI Premium – FREE
Windtree Therapeutics (NASDAQ: WINT) reported Q1 EPS of ($1.70), $0.12 worse than the analyst estimate of ($1.58). Revenue for the quarter came in at $75 thousand, versus $191 thousand reported last year.
For earnings history and earnings-related data on Windtree Therapeutics (WINT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Williams Trading Downgrades Birkenstock Holding plc (BIRK) to Sell, 'Stock Less Comfortable than the Shoes'
- Kotak Upgrades L&T Financial Holdings (LTFH:IN) to Add (2)
- Axis Bank Ltd. (AXSB:IN) PT Raised to INR1,620 at JPMorgan
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
